The smarter surveillance systems become, the more important it is for organizations to know where their data goes, how it is protected, and who has access to it. As artificial intelligence (AI) ...

Recursive, an AI startup founded last year, is starting to live up to its name. The company, which is trying to build AI that can improve itself, released its first model, Flint, on Wednesday. Flint ...

SAIC has added ISC to its cybersecurity portfolio ISC develops encryption and credential management products The deal bolsters SAIC’s zero trust and PQC offerings SAIC has finalized its acquisition of ...

Science Applications International Corp. has moved to expand its zero-trust, quantum and encryption technology capabilities by acquiring a developer of cryptographic software. SAIC has acquired ...

Last year stagflation was a legitimate concern. Real gross domestic product rose only 2.2%, while business-to-business spending declined in real terms. In the fourth quarter last year, real GDP rose ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Regan Peng is an AI founder and former senior tech executive, focused on personal AI, ...

“Recursive self-improvement” is the idea that artificial intelligence could learn to build and train itself, creating exponential new progress — and risk. Jeff Clune, a computer scientist and ...

How do you get from a chatbot that sometimes makes things up to a machine that humans might struggle to control? There are several steps in that argument, and plenty of uncertainty. But an idea known ...

Recursion Pharmaceuticals, Inc. remains a Hold as competitive advances and slow revenue growth challenge its AI-driven drug discovery ambitions. RXRX's partnerships, notably with Genentech/Roche and ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Roche Holding AG advanced the first project from its AI drug-discovery partnership with Recursion Pharmaceuticals, marking an early test of whether artificial intelligence can uncover new medicines.

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...